Modifying the crystallization of amorphous magnesium-calcium phosphate nanoparticles with proteins from Moringa oleifera seeds.

HYPOTHESIS

Endogenous Amorphous Magnesium-Calcium Phosphates (AMCPs) form in the human body and, besides their biomedical implications, the development of effective stabilization strategies is an open challenge. An interesting approach consists of stabilizing amorphous phosphates with macromolecules that have beneficial effects from a nutritional/medical point of view, for a potential application of the hybrid particles in nutraceutics or drug delivery.

EXPERIMENTAL

We investigated the effect of proteins extracted from Moringa oleifera seeds (MO) on the features of synthetic analogs of AMCPs and on their crystallization pathway. The stability of the amorphous phase was studied using infrared spectroscopy and X-ray diffraction. To unravel the effect of the protein on the nano-scale structure of the inorganic particles, we also studied how MO affects the features of the amorphous phase using thermal analysis, small angle X-ray scattering and confocal Raman microscopy.

FINDINGS

We observed that MO markedly delays the transition from amorphous to crystalline phosphate in a concentration-dependent fashion. Interestingly, MO not only enhances the lifetime of the amorphous phase, but also influences the type and amount of crystalline material formed. The results are relevant from both a fundamental and an applied perspective, paving the way for the use of these hybrids in the field of nutraceutics and drug delivery.